Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.6900
+0.0340 (5.18%)
At close: Apr 2, 2025, 4:00 PM
0.6708
-0.0192 (-2.78%)
After-hours: Apr 2, 2025, 7:56 PM EDT

Adial Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-13.2-5.12-12.73-19.42-10.89
Upgrade
Depreciation & Amortization
0000.060
Upgrade
Asset Writedown & Restructuring Costs
---1.55-
Upgrade
Loss (Gain) on Equity Investments
0.550.19---
Upgrade
Stock-Based Compensation
0.81.753.374.242.01
Upgrade
Other Operating Activities
4.54-1.831.940.17-
Upgrade
Change in Accounts Payable
0.17-0.160.02-0.350.62
Upgrade
Change in Other Net Operating Assets
0.22-0.63-1.191.820.62
Upgrade
Operating Cash Flow
-6.92-6.81-11.19-11.95-7.63
Upgrade
Capital Expenditures
----0.06-
Upgrade
Sale of Property, Plant & Equipment
-1.5---
Upgrade
Cash Acquisitions
---0.03-
Upgrade
Other Investing Activities
-----0.35
Upgrade
Investing Cash Flow
-1.5--0.03-0.35
Upgrade
Issuance of Common Stock
7.850.759.1313.646.17
Upgrade
Repurchase of Common Stock
--0---
Upgrade
Other Financing Activities
-3.38---0.56
Upgrade
Financing Cash Flow
7.854.139.1313.645.61
Upgrade
Net Cash Flow
0.92-1.17-2.061.66-2.38
Upgrade
Free Cash Flow
-6.92-6.81-11.19-12.01-7.63
Upgrade
Free Cash Flow Per Share
-1.43-4.78-11.17-16.16-15.31
Upgrade
Levered Free Cash Flow
-3.99-3.29-4.67-5.33-3.57
Upgrade
Unlevered Free Cash Flow
-3.99-3.29-4.67-5.33-3.57
Upgrade
Change in Net Working Capital
-0.390.731.26-1.5-1.13
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q